NEWS #Genetic Engineering
FDA Halts New Clinical Trials That Export Americans’ Cells to Foreign Labs in Hostile Countries for Genetic Engineering
This blog post delves into the recent decision by the FDA to pause clinical trials that involve the transfer of US citizens' biological material to foreign laboratories in countries with potentially adversarial relations. It examines the implications for international collaboration in biomedical research, the balance between innovation and national security, and the potential impacts on the field of genetic engineering. Read on to explore the nuances of this significant development.